This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System.
International journal of clinical pharmacy
Citation
Seijas-Amigo, Jose; Salgado-Barreira, Ángel; Rodriguez-Penas, Diego; Cardeso-Paredes, Begoña; Ribeiro-Ferreiro, Marta; Rodriguez-Mañero, Moisés; Gonzalez-Juanatey, Jose Ramon. (2026). Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System.. International journal of clinical pharmacy. https://doi.org/10.1007/s11096-026-02099-y